|[September 18, 2013]
NIH Awards $6.9 Million to NDRI for Recovery of Human Tissues and Organs for Research
PHILADELPHIA --(Business Wire)--
The National Institutes of Health (NIH) have awarded $6,865,689 to the
National Disease Research Interchange (NDRI) to continue funding the
recovery and distribution of human organs and tissues for medical
The five-year award funds the Research Resource for Human Tissues and
Organs (RRHTO) Cooperative Agreement. Established in 1987, the RRHTO
provides biomedical investigators with donated normal and diseased human
tissues and organs, recovered using customized procurement, processing,
preservation and distribution protocols from a diverse donor pool. A
core grant from the NIH Office of the Director, Office of Research
Infrastructure Programs, is supplemented with additional funding from
the National Center for Advancing Translational Sciences (NCATS),
National Eye Institute (NEI (News - Alert)), National Heart, Lung, and Blood Institute
(NHLBI), National Institute of Allergy and Infectious Diseases (NIAID),
National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS), National Institute of Diabetes and Digestive and Kidney
"Medical researchers encounter a broad range of challenges and
obstacles. Because of NIH's continued support for NDRI's work, accessing
high quality human biospecimens is not among the obstacles," said
Meenhard Herlyn, D.V.M., D. Sc., professor at Wistar Istitute,
Philadelphia, and chairman of the NDRI board of directors.
A unique element of NDRI's work supported through this agreement is the
provision and distribution of human tissue for rare disease research.
The Office of Rare Diseases Research within NCATS provides funds for
outreach to rare disease patients and advocates, and to their medical
and research communities, for the collection and distribution of rare
Funding from NIAID is particularly used to obtain tissues and organs
from HIV-infected donors for the HIV/AIDS biomedical research community.
NHLBI provides funds primarily for tissue collection, storage and
distribution in support of research into the rare lung disease
lymphangioleiomyomatosis (LAM), as well as other heart, lung, and blood
"Support from the NIH affirms the strong value of our mission and work
and the importance of the use of human tissue, organs and cells in
advancing medical research," said NDRI President and CEO Bill Leinweber.
"With leadership from our staff, Dr. John Lonsdale, principal
investigator of the human tissue resource program, and Sally Stickler,
acting director of the program, we look forward to continuing to serve
the research community in the U.S. and around the world. We are grateful
to the NIH for their continued support."
NDRI is a not-for-profit, (501) (c)(3) founded in 1980, funded in part
by the National Institutes of Health (NIH), public and private
foundations and organizations, and pharmaceutical corporations. For more
than 30 years, NDRI has revolutionized the progress of scientific
research by partnering with organ and tissue donation programs to
procure and distribute human biospecimens to biomedical researchers.
Each year, NDRI distributes more than 17,000 biospecimens annually to
some 500 researchers. Since 1980, more than 300,000 tissues and organs
have been distributed to more than 5,000 researchers and have resulted
in 2,500 scientific publications. By serving as the liaison between
organ and tissue donors and the research community, NDRI is uniquely
positioned to support breakthrough advances and discoveries that can
affect advances in the treatment and cure of human diseases. For more
information, please visit www.ndriresource.org.
[ Back To Technology News's Homepage ]